Target intelligence / Profile preview

Voltage-gated sodium channel (NaV) (NaV)

Target
NaV
Molecular classification
Ion channel
01

Overview

The voltage-gated sodium channel (NaV) is an integral membrane protein complex essential for the initiation and propagation of action potentials in excitable cells, such as neurons and muscle cells [1, 7]. It consists of a large pore-forming alpha subunit and associated beta subunits that modulate channel kinetics and cellular localization [3]. Upon membrane depolarization, the channel opens to allow a rapid influx of sodium ions, a process fundamental to nerve signaling and muscle contraction [6, 13]. Saxitoxin is a potent, naturally occurring alkaloid neurotoxin that binds with high affinity to Receptor Site 1 in the extracellular pore of the sodium channel, physically occluding the path and preventing ion flow [1, 2, 13]. This interaction is the molecular basis for paralytic shellfish poisoning, a condition characterized by progressive muscle paralysis and potentially fatal respiratory failure [7, 10]. While primarily known as a toxicant, saxitoxin and its derivatives like neosaxitoxin are being investigated as long-acting local anesthetics and analgesics for clinical applications such as chronic pain management and surgical anesthesia [5, 8, 12]. Other sodium channel blockers are already established as standard treatments for epilepsy, neuropathic pain, and cardiac arrhythmias [11, 12].

Other names
Sodium channel proteinVoltage-dependent sodium channelSaxitoxin receptorTetrodotoxin-sensitive sodium channelSite 1 sodium channel
02

Mechanism of action

Selective blockade of the extracellular pore (Site 1) of the alpha subunit, physically occluding the ion conduction path to prevent sodium influx and inhibit action potential propagation.

03

Biological functions

Action potential generationNeuronal excitabilitySignal transductionMuscle contractionElectrogenesis
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseNeuropathic painOther
05

Safety considerations

Respiratory paralysisCardiac arrestNarrow therapeutic windowNeurotoxicitySystemic toxicityRegulatory status as a Schedule 1 chemical weapon
06

Interacting drugs

Saxitoxin

8 more in the full profile.

07

Biomarkers

SCN gene mutations (e.g., SCN1A, SCN9A) [3]Nerve conduction velocity (NCV) [13]Compound muscle action potential (CMAP) [13]Serum or urine saxitoxin levels (for toxicity monitoring) [13]

Beyond the preview

Go deeper on Voltage-gated sodium channel (NaV) (NaV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated sodium channel (NaV) (NaV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call